BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar VE, Nambiar R, De Souza C, Nguyen A, Chien J, Lam KS. Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior. Cells 2022;11:1403. [DOI: 10.3390/cells11091403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Z, Tan Y, Huang C, Wei X. Redox signaling in drug-tolerant persister cells as an emerging therapeutic target. EBioMedicine 2023;89:104483. [PMID: 36827719 DOI: 10.1016/j.ebiom.2023.104483] [Reference Citation Analysis]
2 Guo Y, Chen X, Zhang X, Hu X. UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb. Front Oncol 2023;13:992233. [PMID: 36860312 DOI: 10.3389/fonc.2023.992233] [Reference Citation Analysis]
3 Roy A, Padhi SS, Khyriem I, Nikose S, Sankar S. H H, Bharathavikru RS. Resetting the epigenome: Methylation dynamics in cancer stem cells. Front Cell Dev Biol 2022;10:909424. [DOI: 10.3389/fcell.2022.909424] [Reference Citation Analysis]
4 F. V, V. D. P, C. M, M. LI, C. D, G. P, D. C, A. T, M. G, S. DF, M. T, V. V, G. S. Targeting epigenetic alterations in cancer stem cells. Front Mol Med 2022;2. [DOI: 10.3389/fmmed.2022.1011882] [Reference Citation Analysis]
5 Hilton J, Cristea M, Postel-vinay S, Baldini C, Voskoboynik M, Edenfield W, Shapiro GI, Cheng ML, Vuky J, Corr B, Das S, Apfel A, Xu K, Kozicki M, Ünsal-kaçmaz K, Hammell A, Wang G, Ravindran P, Kollia G, Esposito O, Coker S, Diamond JR. BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial. Cancers 2022;14:4079. [DOI: 10.3390/cancers14174079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Muylaert C, Van Hemelrijck LA, Maes A, De Veirman K, Menu E, Vanderkerken K, De Bruyne E. Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity? Front Oncol 2022;12:979569. [DOI: 10.3389/fonc.2022.979569] [Reference Citation Analysis]
7 Telang NT. Stem Cell Models for Breast and Colon Cancer: Experimental Approach for Drug Discovery. IJMS 2022;23:9223. [DOI: 10.3390/ijms23169223] [Reference Citation Analysis]
8 Soner BC, Açikgöz E, Öktem G, Çal Ç. Effect of Zoledronic Acid Treatment on Cell Adhesion Molecules in Prostate Cancer Stem Cells. Uludağ Tıp Derg 2022. [DOI: 10.32708/uutfd.1137962] [Reference Citation Analysis]